FLT1 and renal cell carcinoma: Previous studies investigated the role of von Hippel–Lindau mutation, hypoxia-inducing factor (HIF), and vascular endothelial growth factor (VEGF) (3) however, limited ones investigated the role of other proangiogenic molecules such as Nestin and FLT1 in RCC.